About
Technology
Issues
FAQ
Links
Official Page
Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.